Krembil Research Institute
Results: 1
# | Item |
---|---|
1 | AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid LeuAdd to Reading ListSource URL: www.ccrm.caLanguage: English - Date: 2016-02-18 12:07:01 |